Publications by authors named "Jinxing Ji"

Claim this Profile
N
Network pharmacology analysis and clinical efficacy study of Fuzi Lizhong Decoction combined with XELOX plus sintilimab in the treatment of advanced gastric cancer.
Wei Zhang, Wei Hu, Jinxing Ji, Weipeng Liu, Lirong Deng

Medicine (Baltimore)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
With whom should I work? Partners' network characteristics and innovation persistence.
Jinxing Ji

Heliyon· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When and how scientists influence technological performance: A moderated mediation model.
Jinxing Ji, Jieyu Song, Na Liu

PLoS One· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-17-3p Facilitates Aggressive Cell Phenotypes in Colon Cancer by Targeting PLCD1 Through Affecting KIF14.
Jinxing Ji, Jun Fu

Appl Biochem Biotechnol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant human endostatin injection (Endostar) combined with PF chemotherapy and sequential intensity-modulated radiotherapy is tolerable and improves prognosis of locally advanced nasopharyngeal carcinoma: a randomized, open, multicenter phase II clinical study.
Lu Xu, Dailong Li, Jinxing Ji, Zhuo Chen, Xi Tang

Am J Cancer Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sintilimab combined with apatinib plus capecitabine in the treatment of unresectable hepatocellular carcinoma: A prospective, open-label, single-arm, phase II clinical study.
Dailong Li, Lu Xu, Jinxing Ji, Dan Bao, Juan Hu, Yinjie Zhou

Front Immunol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis